MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 2, 2004; DOI: 10.1124/mol.104.000125


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.000125v1
66/4/964    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dunbar, A. Y
Right arrow Articles by Osawa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dunbar, A. Y
Right arrow Articles by Osawa, Y.


Received for publication March 5, 2004.
Revised June 9, 2004.
Accepted for publication July 2, 2004.

UBIQUITINATION AND DEGRADATION OF NEURONAL NO-SYNTHASE IN VITRO: DIMER STABILIZATION PROTECTS THE ENZYME FROM PROTEOLYSIS

Anwar Y Dunbar 1, Yasuhiko Kamada 1, Gary J Jenkins 1, Ezra R Lowe 1, Scott S Billecke 1, Yoichi Osawa 1*

1 University of Michigan Medical School

* Address correspondence to: E-mail: osawa{at}umich.edu

Abstract

It is established that neuronal NO synthase (nNOS) is ubiquitinated and proteasomally degraded. The metabolism-based inactivation of nNOS as well as the inhibition of hsp90-based chaperones, which are known to regulate nNOS, both lead to enhanced proteasomal degradation of nNOS. The mechanism of this selective proteolytic degradation, or in essence how the nNOS becomes labilized and recognized for ubiquitination and subsequent degradation, has not been determined. In the current study, we used a crude preparation of reticulocyte proteins, which contains ubiquitin conjugating enzymes and the proteasome, to determine how nNOS is labilized. We found that the inactive monomeric heme-deficient apo-nNOS is rapidly degraded in vitro, consistent with the finding that both metabolism-based inactivation and inhibition of hsp90-based chaperones cause the formation of apo-nNOS and enhance its degradation in vivo. In the current study we discovered that destabilization of the dimeric nNOS, as determined by measuring the SDS-resistant dimer, is sufficient to trigger ubiquitin-proteasomal degradation. Treatment of nNOS with NG-nitro-L-arginine or 7-nitroindazole led to stabilization of the dimeric nNOS and decreased proteasomal degradation of the enzyme, consistent with that observed in cells. Thus, it appears that the dimeric structure is a major determinant of nNOS stability and proteolysis.


Key words: Nitric oxide synthases, Regulation - post-transcriptional, Reactive intermediates


This article has been cited by other articles:


Home page
Mol Biol EvolHome page
V. Ruano-Rubio and M. A. Fares
Testing the Neutral Fixation of Hetero-Oligomerism in the Archaeal Chaperonin CCT
Mol. Biol. Evol., June 1, 2007; 24(6): 1384 - 1396.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. C. Carreras and J. J. Poderoso
Mitochondrial nitric oxide in the signaling of cell integrated responses
Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1569 - C1580.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
A. Y. Dunbar, G. J. Jenkins, S. Jianmongkol, M. Nakatsuka, E. R. Lowe, M. Lau, and Y. Osawa
Tetrahydrobiopterin Protects against Guanabenz-Mediated Inhibition of Neuronal Nitric-Oxide Synthase in Vitro and in Vivo
Drug Metab. Dispos., September 1, 2006; 34(9): 1448 - 1456.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
C. E. Wood and D. Giroux
Expression of Nitric Oxide Synthase Isoforms in the Ovine Fetal Brain: Alteration by Hormonal and Hemodynamic Stimuli
Reproductive Sciences, July 1, 2006; 13(5): 329 - 337.
[Abstract] [PDF]


Home page
Nucleic Acids ResHome page
I. Ispolatov, A. Yuryev, I. Mazo, and S. Maslov
Binding properties and evolution of homodimers in protein-protein interaction networks
Nucleic Acids Res., June 27, 2005; 33(11): 3629 - 3635.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics